# Validation of the Genetic Signature 354849 as a Prognostic Method

> **NCT04067882** · — · UNKNOWN · sponsor: **National Institute of Cancerología** · enrollment: 189 (estimated)

## Conditions studied

- Cervix Cancer

## Interventions

- **OTHER:** Genetic signature

## Key facts

- **NCT ID:** NCT04067882
- **Lead sponsor:** National Institute of Cancerología
- **Sponsor class:** OTHER_GOV
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-09-30
- **Primary completion:** 2024-05-30
- **Final completion:** 2024-05-30
- **Target enrollment:** 189 (ESTIMATED)
- **Last updated:** 2023-11-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04067882

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04067882, "Validation of the Genetic Signature 354849 as a Prognostic Method". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04067882. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*